78 related articles for article (PubMed ID: 27311861)
1. Decreased HCRP1 promotes breast cancer metastasis by enhancing EGFR phosphorylation.
Yang W; Wang JG; Wang Q; Qin Y; Lin X; Zhou D; Ren K; Hou C; Xu J; Liu X
Biochem Biophys Res Commun; 2016 Aug; 477(2):222-8. PubMed ID: 27311861
[TBL] [Abstract][Full Text] [Related]
2. HCRP1 downregulation promotes hepatocellular carcinoma cell migration and invasion through the induction of EGFR activation and epithelial-mesenchymal transition.
Xu J; Zhang X; Wang H; Ge S; Gao T; Song L; Wang X; Li H; Qin Y; Zhang Z
Biomed Pharmacother; 2017 Apr; 88():421-429. PubMed ID: 28122307
[TBL] [Abstract][Full Text] [Related]
3. Decreased HCRP1 expression is associated with poor prognosis in breast cancer patients.
Xu J; Yang W; Wang Q; Zhang Q; Li X; Lin X; Liu X; Qin Y
Int J Clin Exp Pathol; 2014; 7(11):7915-22. PubMed ID: 25550832
[TBL] [Abstract][Full Text] [Related]
4. HCRP1 regulates proliferation, invasion, and drug resistance via EGFR signaling in prostate cancer.
Sun L; Lü J; Ding S; Bi D; Ding K; Niu Z; Liu P
Biomed Pharmacother; 2017 Jul; 91():202-207. PubMed ID: 28458158
[TBL] [Abstract][Full Text] [Related]
5. HCRP1 downregulation confers poor prognosis and induces chemoresistance through regulation of EGFR-AKT pathway in human gastric cancer.
Xu H; Miao ZF; Wang ZN; Zhao TT; Xu YY; Song YX; Huang JY; Zhang JY; Liu XY; Wu JH; Xu HM
Virchows Arch; 2017 Dec; 471(6):743-751. PubMed ID: 28963677
[TBL] [Abstract][Full Text] [Related]
6. Loss of HCRP1 leads to upregulation of PD-L1 via STAT3 activation and is of prognostic significance in EGFR-dependent cancer.
Tomasich E; Topakian T; Heller G; Udovica S; Krainer M; Marhold M
Transl Res; 2021 Apr; 230():21-33. PubMed ID: 33197651
[TBL] [Abstract][Full Text] [Related]
7. Up-regulation of HCRP1 inhibits proliferation and invasion in glioma cells via suppressing the ERK and AKT signaling pathways.
Xu CY; Li ZJ; Hu WZ
Biomed Pharmacother; 2017 Nov; 95():31-36. PubMed ID: 28826094
[TBL] [Abstract][Full Text] [Related]
8. HCRP1 inhibits cell proliferation and invasion and promotes chemosensitivity in esophageal squamous cell carcinoma.
Wu Y; Yang Y; Xian YS
Chem Biol Interact; 2019 Aug; 308():357-363. PubMed ID: 31152734
[TBL] [Abstract][Full Text] [Related]
9. HCRP1 is downregulated in non-small cell lung cancer and regulates proliferation, invasion, and drug resistance.
Du Y; Wang P; Sun H; Yang J; Lang X; Wang Z; Zang S; Chen L; Ma J; Sun D
Tumour Biol; 2016 Oct; ():. PubMed ID: 27739029
[TBL] [Abstract][Full Text] [Related]
10. The growth-regulatory protein HCRP1/hVps37A is a subunit of mammalian ESCRT-I and mediates receptor down-regulation.
Bache KG; Slagsvold T; Cabezas A; Rosendal KR; Raiborg C; Stenmark H
Mol Biol Cell; 2004 Sep; 15(9):4337-46. PubMed ID: 15240819
[TBL] [Abstract][Full Text] [Related]
11. EGFR inhibition by (-)-epigallocatechin-3-gallate and IIF treatments reduces breast cancer cell invasion.
Farabegoli F; Govoni M; Spisni E; Papi A
Biosci Rep; 2017 Jun; 37(3):. PubMed ID: 28465354
[TBL] [Abstract][Full Text] [Related]
12. Platycodin D inhibits migration, invasion, and growth of MDA-MB-231 human breast cancer cells via suppression of EGFR-mediated Akt and MAPK pathways.
Chun J; Kim YS
Chem Biol Interact; 2013 Oct; 205(3):212-21. PubMed ID: 23867902
[TBL] [Abstract][Full Text] [Related]
13. HCRP-1 regulates cell migration and invasion via EGFR-ERK mediated up-regulation of MMP-2 with prognostic significance in human renal cell carcinoma.
Chen F; Deng J; Liu X; Li W; Zheng J
Sci Rep; 2015 Aug; 5():13470. PubMed ID: 26304749
[TBL] [Abstract][Full Text] [Related]
14. hVps37A Status affects prognosis and cetuximab sensitivity in ovarian cancer.
Wittinger M; Vanhara P; El-Gazzar A; Savarese-Brenner B; Pils D; Anees M; Grunt TW; Sibilia M; Holcmann M; Horvat R; Schemper M; Zeillinger R; Schöfer C; Dolznig H; Horak P; Krainer M
Clin Cancer Res; 2011 Dec; 17(24):7816-27. PubMed ID: 22016507
[TBL] [Abstract][Full Text] [Related]
15. The interplay of HER2/HER3/PI3K and EGFR/HER2/PLC-γ1 signalling in breast cancer cell migration and dissemination.
Balz LM; Bartkowiak K; Andreas A; Pantel K; Niggemann B; Zänker KS; Brandt BH; Dittmar T
J Pathol; 2012 Jun; 227(2):234-44. PubMed ID: 22262199
[TBL] [Abstract][Full Text] [Related]
16. Distinct mechanisms mediate the initial and sustained phases of cell migration in epidermal growth factor receptor-overexpressing cells.
Kruger JS; Reddy KB
Mol Cancer Res; 2003 Sep; 1(11):801-9. PubMed ID: 14517342
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA-133b inhibits proliferation and invasion of ovarian cancer cells through Akt and Erk1/2 inactivation by targeting epidermal growth factor receptor.
Liu X; Li G
Int J Clin Exp Pathol; 2015; 8(9):10605-14. PubMed ID: 26617770
[TBL] [Abstract][Full Text] [Related]
18. A role for phospholipase C-gamma-mediated signaling in tumor cell invasion.
Kassis J; Moellinger J; Lo H; Greenberg NM; Kim HG; Wells A
Clin Cancer Res; 1999 Aug; 5(8):2251-60. PubMed ID: 10473113
[TBL] [Abstract][Full Text] [Related]
19. Identification of epidermal growth factor receptor and its inhibitory microRNA141 as novel targets of Krüppel-like factor 8 in breast cancer.
Li T; Lu H; Mukherjee D; Lahiri SK; Shen C; Yu L; Zhao J
Oncotarget; 2015 Aug; 6(25):21428-42. PubMed ID: 26025929
[TBL] [Abstract][Full Text] [Related]
20. EGFR/HER2 inhibitors effectively reduce the malignant potential of MDR breast cancer evoked by P-gp substrates in vitro and in vivo.
Jin Y; Zhang W; Wang H; Zhang Z; Chu C; Liu X; Zou Q
Oncol Rep; 2016 Feb; 35(2):771-8. PubMed ID: 26718028
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
